Shih-Feng Cho1,2, Kun-Ming Rau3,4, Yu-Yun Shao5, Chia-Jui Yen6, Ming-Fang Wu7,8, Jen-Shi Chen4,9, Cheng-Shyong Chang10, Su-Peng Yeh11, Tzeon-Jye Chiou12,13, Ruey-Kuen Hsieh14, Ming-Yang Lee15, Yung-Chuan Sung16,17, Kuan-Der Lee18, Pang-Yu Lai19, Ming-Sun Yu20, Wen-Li Hwang21, Ta-Chih Liu22. 1. Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan. 2. Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. 3. Division of Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. 4. College of Medicine, Chang Gung University, Taoyuan, Taiwan. 5. Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. 6. Division of Hematology and Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan. 7. School of Medicine, Chung Shan Medical University, Taichung, Taiwan. 8. Division of Medical Oncology, Chung Shan Medical University Hospital, Taichung, Taiwan. 9. Division of Medical Oncology in the Hematology and Oncology, Department of Internal Medicine,, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan. 10. Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan. 11. Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan. 12. Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. 13. School of Medicine, National Yang-Ming University, Taipei, Taiwan. 14. Division of Hematology and Oncology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan. 15. School of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan. 16. Department of Oncology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan. 17. Division of Hematology-Oncology, Department of Internal Medicine, Cathay General Hospital, Taipei, Taiwan. 18. Division of Hematology and Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chia-yi, Taiwan. 19. Division of Hematology and Oncology, E-DA Hospital, Kaohsiung, Taiwan. 20. Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. 21. Division of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. 22. Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100, Tzyou 1st Road, Kaohsiung, 807, Taiwan. d730093@cc.kmu.edu.tw.
Abstract
PURPOSE: The purpose of this study is to investigate the prevalence of pain, pain management, and impact of recent pain on daily functioning in patients with head and neck cancer (HNC) and patients with other cancers. METHODS: This multi-center survey was conducted by using Brief Pain Inventory questionnaire to evaluate pain status and its impact on daily functioning. RESULTS: A total of 3289 patients were analyzed including 708 HNC patients and 2581 patients with other cancers. The overall pain prevalence was 69.17%. A higher percentage of HNC patients had recent pain (60.59 vs. 44.01%, P < 0.001), required pain management (86.29 vs. 72.03%, P < 0.001), and used any analgesics (53.81 vs. 34.52%, P < 0.001). HNC patients with pain management had a higher prevalence of recent pain (85.83 vs. 81.14%, P = 0.044) and a slightly lower satisfaction rate (74.00 vs. 79.70%, P = 0.070). Regarding the impact of pain on daily functioning, HNC patients had a lower mean interference score for general activity such as walking, normal work, sleep, and life enjoyment. CONCLUSIONS: The HNC patients may need more intensive pain management to achieve optimal pain control and maintain daily functioning.
PURPOSE: The purpose of this study is to investigate the prevalence of pain, pain management, and impact of recent pain on daily functioning in patients with head and neck cancer (HNC) and patients with other cancers. METHODS: This multi-center survey was conducted by using Brief Pain Inventory questionnaire to evaluate pain status and its impact on daily functioning. RESULTS: A total of 3289 patients were analyzed including 708 HNC patients and 2581 patients with other cancers. The overall pain prevalence was 69.17%. A higher percentage of HNC patients had recent pain (60.59 vs. 44.01%, P < 0.001), required pain management (86.29 vs. 72.03%, P < 0.001), and used any analgesics (53.81 vs. 34.52%, P < 0.001). HNC patients with pain management had a higher prevalence of recent pain (85.83 vs. 81.14%, P = 0.044) and a slightly lower satisfaction rate (74.00 vs. 79.70%, P = 0.070). Regarding the impact of pain on daily functioning, HNC patients had a lower mean interference score for general activity such as walking, normal work, sleep, and life enjoyment. CONCLUSIONS: The HNC patients may need more intensive pain management to achieve optimal pain control and maintain daily functioning.
Entities:
Keywords:
Daily functioning; Head and neck cancer; Multi-center study; Pain management; Prevalence of pain
Authors: Vitaliana De Sanctis; Paolo Bossi; Giuseppe Sanguineti; Fabio Trippa; Daris Ferrari; Almalina Bacigalupo; Carla Ida Ripamonti; Michela Buglione; Stefano Pergolizzi; Johannes A Langendjik; Barbara Murphy; Judith Raber-Durlacher; Elvio G Russi; Rajesh V Lalla Journal: Crit Rev Oncol Hematol Date: 2016-02-01 Impact factor: 6.312
Authors: Edwin S Wong; Bruce C M Wang; Louis P Garrison; Rafael Alfonso-Cristancho; David R Flum; David E Arterburn; Sean D Sullivan Journal: BMC Med Res Methodol Date: 2011-12-28 Impact factor: 4.615
Authors: Evelien H van der Peet; Marieke H J van den Beuken-van Everdingen; Jacob Patijn; Harry C Schouten; Maarten van Kleef; Annemie M Courtens Journal: Support Care Cancer Date: 2008-12-23 Impact factor: 3.603
Authors: Jia-Hua Wang; Ling-Wei Wang; Shu-Yuan Liang; John Rosenberg; Tsae-Jyy Wang; Shu-Fang Wu; Chieh-Yu Liu Journal: Support Care Cancer Date: 2022-01-03 Impact factor: 3.603